BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27787871)

  • 1. Experimental Approaches for Studying Semaphorin Signals in Tumor Growth and Metastasis in Mouse Models.
    Moiso E; Accardo M; Tamagnone L
    Methods Mol Biol; 2017; 1493():467-484. PubMed ID: 27787871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin.
    Capparuccia L; Tamagnone L
    J Cell Sci; 2009 Jun; 122(Pt 11):1723-36. PubMed ID: 19461072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of immune semaphorin/plexin signaling to carcinogenesis.
    Műzes G; Sipos F
    Eur J Cancer Prev; 2014 Sep; 23(5):469-76. PubMed ID: 24922268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorin signals tweaking the tumor microenvironment.
    Muratori C; Tamagnone L
    Adv Cancer Res; 2012; 114():59-85. PubMed ID: 22588056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semaphorins in cancer: biological mechanisms and therapeutic approaches.
    Rehman M; Tamagnone L
    Semin Cell Dev Biol; 2013 Mar; 24(3):179-89. PubMed ID: 23099250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin signals on the road to cancer invasion and metastasis.
    Rizzolio S; Tamagnone L
    Cell Adh Migr; 2007; 1(2):62-8. PubMed ID: 19329883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer.
    Mastrantonio R; You H; Tamagnone L
    Theranostics; 2021; 11(7):3262-3277. PubMed ID: 33537086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semaphorin Signaling in Cancer-Associated Inflammation.
    Franzolin G; Tamagnone L
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of class 3 semaphorins as both targets and therapeutics in cancer.
    Mishra R; Kumar D; Tomar D; Chakraborty G; Kumar S; Kundu GC
    Expert Opin Ther Targets; 2015 Mar; 19(3):427-42. PubMed ID: 25434284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin signaling in bone.
    Verlinden L; Vanderschueren D; Verstuyf A
    Mol Cell Endocrinol; 2016 Sep; 432():66-74. PubMed ID: 26365296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The semaphorins and their receptors as modulators of tumor progression.
    Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
    Drug Resist Updat; 2016 Nov; 29():1-12. PubMed ID: 27912840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin signaling in vascular and tumor biology.
    Neufeld G; Lange T; Varshavsky A; Kessler O
    Adv Exp Med Biol; 2007; 600():118-31. PubMed ID: 17607951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorins in health and disease.
    Fard D; Tamagnone L
    Cytokine Growth Factor Rev; 2021 Feb; 57():55-63. PubMed ID: 32900601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer.
    Tamagnone L
    Cancer Cell; 2012 Aug; 22(2):145-52. PubMed ID: 22897846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorins and their receptors in stem and cancer cells.
    Micucci C; Orciari S; Catalano A
    Curr Med Chem; 2010; 17(30):3462-75. PubMed ID: 20738252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis.
    Christensen C; Ambartsumian N; Gilestro G; Thomsen B; Comoglio P; Tamagnone L; Guldberg P; Lukanidin E
    Cancer Res; 2005 Jul; 65(14):6167-77. PubMed ID: 16024618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging roles and mechanisms of semaphorins activity in cancer.
    Bica C; Tirpe A; Nutu A; Ciocan C; Chira S; Gurzau ES; Braicu C; Berindan-Neagoe I
    Life Sci; 2023 Apr; 318():121499. PubMed ID: 36775114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin signaling: molecular switches at the midline.
    Derijck AA; Van Erp S; Pasterkamp RJ
    Trends Cell Biol; 2010 Sep; 20(9):568-76. PubMed ID: 20655749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.